e-learning
resources
Vienna 2012
Monday, 03.09.2012
Pharmacological and non-pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy
Y. Wang, L. Tao, G. Shi, H. Wan, X. Cai, H. Zhu (Shanghai, China)
Source:
Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Session:
Pharmacological and non-pharmacological management of COPD
Session type:
Poster Discussion
Number:
2910
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Wang, L. Tao, G. Shi, H. Wan, X. Cai, H. Zhu (Shanghai, China). Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy. Eur Respir J 2012; 40: Suppl. 56, 2910
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence,determinants and impact of nocturnal hypoxemia in COPD patients not candidates for domiciliary oxygen therapy
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Predictors of nocturnal desaturation in COPD patients with mild daytime hypoxaemia
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003
Nocturnal hypercapnia and oxygen therapy in COPD patients
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005
Benefits of long-term oxygen therapy among COPD patients with moderate resting desaturation
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
Usefulness of daytime arterial blood gases in detection of nocturnal respiratory acidosis in COPD patients undergoing LTOT
Source: Eur Respir J 2002; 20: Suppl. 38, 86s
Year: 2002
Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Persistent daytime hypercapnia predicts poor prognosis in OSAS undergoing CPAP therapy
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Does long-term oxygen therapy reduce hospitalisation in hypoxaemic COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 274s
Year: 2001
Domiciliary ambulatory oxygen is not beneficial in patients with COPD and mild resting hypoxaemia
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010
PaO
2
during exercise as a predictor for in-flight hypoxemia in COPD patients
Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange
Year: 2008
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation
Source: Eur Respir J 2001; 17: 848-855
Year: 2001
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Prevalence and contributing factors for daytime and nocturnal hypoxia in chronic heart failure patients
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Predicting response to oxygen therapy in obstructive sleep apnoea patients using a 10-minute daytime test
Source: Eur Respir J, 51 (1) 1701587; 10.1183/13993003.01587-2017
Year: 2018
Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients
Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019
Year: 2020
Factors predicting nocturnal hypoxemia in severe COPD with and without nutritional depletion
Source: Eur Respir J 2002; 20: Suppl. 38, 499s
Year: 2002
Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?
Source: Eur Respir J 2002; 20: 38-42
Year: 2002
Predictors of nocturnal hypoxaemia in COPD patients with arterial oxygen tensions above 60 mmHg
Source: Eur Respir J 2001; 18: Suppl. 33, 87s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept